Lv1
50 积分 2024-05-08 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
9天前
已完结
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
5个月前
已完结
皖公网安备34019202002308
